Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PALI | AMGN | GILD | BMY | VRTX |
| Company | Palisade Bio Inc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.8700 | 262.18 | 92.62 | 56.93 | 403.14 |
| High | 1.9800 | 263.58 | 92.83 | 57.38 | 409.60 |
| Low | 1.7600 | 258.31 | 91.40 | 56.52 | 402.72 |
| Last | 1.8600 | 259.28 | 91.88 | 56.79 | 405.76 |
| Change | +0.2100 | -1.36 | -0.49 | +0.23 | +3.06 |
| % Change | +12.73% | -0.52% | -0.53% | +0.41% | +0.76% |
| Volume | 512,500 | 2,357,900 | 3,496,000 | 9,093,600 | 1,277,800 |
| 20-Day Average Volume | 3,753,375 | 3,757,990 | 6,799,140 | 11,264,160 | 1,887,665 |
| Previous Close | 1.6500 | 260.64 | 92.37 | 56.56 | 402.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7760 | 267.30 | 92.40 | 57.33 | 437.24 |
| 20-Day Raw Stochastic | 25.00% | 22.40% | 49.64% | 37.08% | 28.30% |
| 20-Day Relative Strength | 44.37% | 31.41% | 51.41% | 50.12% | 35.42% |
| Weighted Alpha | -75.14 | -19.55 | +19.58 | +16.07 | -9.93 |
| Today's Opinion | 88% Sell | 88% Sell | 88% Buy | 72% Buy | 72% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 88% Buy | 56% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 72% Sell | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.77% since 12/24/24 | -1.97% since 12/24/24 | -2.20% since 12/24/24 | -1.68% since 12/24/24 | -0.59% since 12/24/24 |
| Low | 1.6300 on 12/31/24 | 258.31 on 01/02/25 | 91.40 on 01/02/25 | 55.93 on 12/31/24 | 399.06 on 12/30/24 |
| High | 1.9800 on 01/02/25 | 264.73 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | -22.50% since 12/02/24 | -6.77% since 12/02/24 | -2.28% since 12/02/24 | -5.26% since 12/02/24 | -12.88% since 12/02/24 |
| Low | 1.3800 on 12/11/24 | 253.30 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 |
| High | 3.3000 on 12/12/24 | 281.38 on 12/03/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -45.29% since 10/02/24 | -18.91% since 10/02/24 | +8.43% since 10/02/24 | +5.64% since 10/02/24 | -12.20% since 10/02/24 |
| Low | 1.3800 on 12/11/24 | 253.30 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 | 377.85 on 12/19/24 |
| High | 4.3200 on 10/21/24 | 329.17 on 10/11/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -59.03% since 07/02/24 | -16.57% since 07/02/24 | +34.33% since 07/02/24 | +40.40% since 07/02/24 | -14.36% since 07/02/24 |
| Low | 1.3800 on 12/11/24 | 253.30 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 |
| High | 4.8900 on 07/19/24 | 346.85 on 07/25/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,564 | 140,102,608 | 115,117,592 | 114,713,688 | 103,706,928 |
| Shares Outstanding, K | 2,766 | 537,533 | 1,246,266 | 2,028,177 | 257,529 |
| Annual Sales | 250,000 | 28,190,000,000 | 27,116,000,000 | 45,006,000,000 | 9,869,200,000 |
| Annual Net Income | -12,300,000 | 6,717,000,000 | 5,665,000,000 | 8,025,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 7,545,000,000 | 11,892,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -3,490,000 | 2,830,000,000 | 1,253,000,000 | 1,211,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.39 | 0.55 | 0.18 | 0.45 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 11/12/24 | 5.58 on 10/30/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/14/24 | 02/04/25 | 02/11/25 | 02/06/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.770 on 12/13/24 | 0.620 on 01/03/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 12/13/24 | 01/03/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 20.77 | 47.91 | 0.00 |